Lyme disease

Annals of Internal Medicine

Volumn 157, Issue 3, 2012, Pages

  Hu, Linden T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INSECT REPELLENT; LYME DISEASE VACCINE; PENICILLIN G; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FATIGUE; FEVER; HEADACHE; HEART BLOCK; HOSPITAL ADMISSION; HUMAN; LYME DISEASE; MYALGIA; NEUROLOGIC DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PRURITUS; SEROLOGY; TICK BITE; WESTERN BLOTTING; DIFFERENTIAL DIAGNOSIS; PATIENT EDUCATION; RECURRENT DISEASE; REVIEW; RISK FACTOR;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYME DISEASE; PATIENT EDUCATION AS TOPIC; RECURRENCE; RISK FACTORS;

EID: 84864812174     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-157-3-201208070-01002     Document Type: Article

References (47)

1. des Vignes F, Piesman J, Heffernan R, Schulze TL, Stafford KC 3rd, Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis. 2001;183:773-8. [PMID: 11181154]
2. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J Infect Dis. 1993;167: 1082-5. [PMID: 8486940]
3. Vázquez M, Muehlenbein C, Cartter M, Hayes EB, Ertel S, Shapiro ED. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis. 2008;14:210-6. [PMID: 18258112]
4. Connally NP, Durante AJ, Yousey-Hindes KM, Meek JI, Nelson RS, Heimer R. Peridomestic Lyme disease prevention: results of a population-based case-control study. Am J Prev Med. 2009;37:201-6. [PMID: 19595558]
5. Shapiro ED, Gerber MA, Holabird NB, et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med. 1992;327:1769-73. [PMID: 1435930]
6. Costello CM, Steere AC, Pinkerton RE, Feder HM Jr. A prospective study of tick bites in an endemic area for Lyme disease. J Infect Dis. 1989;159:136-9. [PMID: 2642519]
7. Agre F, Schwartz R. The value of early treatment of deer tick bites for the prevention of Lyme disease. Am J Dis Child. 1993;147:945-7. [PMID: 8362808]
8. Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother. 2010;65:1137-44. [PMID: 20382722]
9. Nadelman RB, Nowakowski J, Fish D, et al. Tick Bite Study Group. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001;345:79-84. [PMID: 11450675]
10. Magid D, Schwartz B, Craft J, Schwartz JS. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med. 1992;327:534-41. [PMID: 1298217]
11. Piesman J, Hojgaard A. Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: An animal model. Ticks Tick Borne Dis. 2012 Mar 13. [Epub ahead of print]. [PMID: 22421585]
12. Krause PJ, Foley DT, Burke GS, Christianson D, Closter L, Spielman A; Tick-Borne Disease Study Group. Reinfection and relapse in early Lyme disease. Am J Trop Med Hyg. 2006;75:1090-4. [PMID: 17172372]
13. Burke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ; Tick-borne Infection Study Group. Hypersensitivity to ticks and Lyme disease risk. Emerg Infect Dis. 2005;11:36-41. [PMID: 15705320]
14. Sigal LH, Zahradnik JM, Lavin P, et al. A vaccine consisting of recombinant Borrelia burgdorferi outersurface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med. 1998;339:216-22. [PMID: 9673299]
15. Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outersurface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med. 1998;339:209-15. [PMID: 9673298]
16. Krause PJ, Telford SR 3rd, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275: 1657-60. [PMID: 8637139]
17. Wang TJ, Liang MH, Sangha O, et al. Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease. Clin Infect Dis. 2000;31: 1149-54. [PMID: 11073744]
18. Tavakoli NP, Wang H, Dupuis M, et al. Fatal case of deer tick virus encephalitis. N Engl J Med. 2009;360:2099-107. [PMID: 19439744]
19. Platonov AE, Karan LS, Kolyasnikova NM, Makhneva NA, Toporkova MG, Maleev VV, et al. Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. 2011;17:1816-23. [PMID: 22000350]
20. Campbell GL, Paul WS, Schriefer ME, Craven RB, Robbins KE, Dennis DT. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993. J Infect Dis. 1995;172:470-80. [PMID: 7622891]
21. Kirkland KB, Klimko TB, Meriwether RA, Schriefer M, Levin M, Levine J, et al. Erythema migrans-like rash illness at a camp in North Carolina: a new tickborne disease? Arch Intern Med. 1997;157:2635-41. [PMID: 9531233]
22. Felz MW, Chandler FW Jr, Oliver JH Jr, Rahn DW, Schriefer ME. Solitary erythema migrans in Georgia and South Carolina. Arch Dermatol. 1999;135:1317-26. [PMID: 10566829]
23. Ramsey AH, Belongia EA, Chyou PH, Davis JP. Appropriateness of Lyme disease serologic testing. Ann Fam Med. 2004;2:341-4. [PMID: 15335133]
24. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33: 780-5. [PMID: 11512082]
25. Tugwell P, Dennis DT, Weinstein A, Wells G, Shea B, Nichol G, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997;127:1109-23. [PMID: 9412316]
26. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA. 1993;269:1812-6. [PMID: 8459513]
27. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzymelinked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187-99. [PMID: 12695997]
28. Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ. Twotiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clin Infect Dis. 2011;53:541-7. [PMID: 21865190]
29. Wormser GP, Liveris D, Hanincová K, et al. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease. Clin Infect Dis. 2008;47: 910-4. [PMID: 18724824]
30. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987;107:725-31. [PMID: 3662285]
31. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22-6. [PMID: 6407378]
32. Dattwyler RJ, Volkman DJ, Conaty SM, Platkin SP, Luft BJ. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 1990;336: 1404-6. [PMID: 1978873]
33. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med. 1992;92:396-403. [PMID: 1313637]
34. Nadelman RB, Luger SW, Frank E, Wisniewski M, Collins JJ, Wormser GP. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992;117:273-80. [PMID: 1637021]
35. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995;39: 661-7. [PMID: 7793869]
36. Luft BJ, Dattwyler RJ, Johnson RC, et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med. 1996;124:785-91. [PMID: 8610947]
37. Dattwyler RJ, Luft BJ, Kunkel MJ, et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337:289-94. [PMID: 9233865]
38. Hansen K, Hovmark A, Lebech AM, et al. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. Acta Derm Venereol. 1992;72: 297-300. [PMID: 1357894]
39. Wormser GP. Lyme disease: insights into the use of antimicrobials for prevention and treatment in the context of experience with other spirochetal infections. Mt Sinai J Med. 1995;62:188-95. [PMID: 7616973]
40. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7:690-5. [PMID:18567539]
41. Seltzer EG, Shapiro ED, Gerber MA. Longterm outcomes of Lyme disease. JAMA. 2000;283:3068-9. [PMID:10865292]
42. Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med. 1999;131:919-26. [PMID: 10610642]
43. Feder HM Jr, Johnson BJ, O'Connell S, et al; Ad Hoc International Lyme Disease Group. A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007;357: 1422-30. [PMID: 17914043]
44. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85-92. [PMID: 11450676]
45. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60: 1923-30. [PMID: 12821734]
46. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebocontrolled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992-1003. [PMID: 17928580]
47. Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A, Schmid CH, Klempner MS. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology. 2003;60:1916-22. [PMID:12821733]